Logo image of TRC

TEJON RANCH CO (TRC) Stock Fundamental Analysis

NYSE:TRC - New York Stock Exchange, Inc. - US8790801091 - Common Stock - Currency: USD

18.49  +0.12 (+0.65%)

After market: 18.84 +0.35 (+1.89%)

Fundamental Rating

3

TRC gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 65 industry peers in the Real Estate Management & Development industry. The financial health of TRC is average, but there are quite some concerns on its profitability. TRC does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year TRC was profitable.
In the past year TRC had a positive cash flow from operations.
TRC had positive earnings in 4 of the past 5 years.
TRC had a positive operating cash flow in each of the past 5 years.
TRC Yearly Net Income VS EBIT VS OCF VS FCFTRC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M

1.2 Ratios

TRC has a Return On Assets of 0.35%. This is in the better half of the industry: TRC outperforms 64.62% of its industry peers.
TRC has a Return On Equity of 0.45%. This is in the better half of the industry: TRC outperforms 66.15% of its industry peers.
Industry RankSector Rank
ROA 0.35%
ROE 0.45%
ROIC N/A
ROA(3y)1.27%
ROA(5y)0.93%
ROE(3y)1.56%
ROE(5y)1.15%
ROIC(3y)N/A
ROIC(5y)N/A
TRC Yearly ROA, ROE, ROICTRC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1 -1 2 3

1.3 Margins

TRC has a better Profit Margin (5.01%) than 80.00% of its industry peers.
In the last couple of years the Profit Margin of TRC has declined.
With a Gross Margin value of 8.10%, TRC is not doing good in the industry: 75.38% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of TRC has declined.
Industry RankSector Rank
OM N/A
PM (TTM) 5.01%
GM 8.1%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-12.59%
PM growth 5Y-21.37%
GM growth 3Y-35.98%
GM growth 5Y-22.35%
TRC Yearly Profit, Operating, Gross MarginsTRC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

More info and screens

5

2. Health

2.1 Basic Checks

TRC does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, TRC has about the same amount of shares outstanding.
The number of shares outstanding for TRC has been increased compared to 5 years ago.
TRC has a worse debt/assets ratio than last year.
TRC Yearly Shares OutstandingTRC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
TRC Yearly Total Debt VS Total AssetsTRC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

TRC has an Altman-Z score of 2.42. This is not the best score and indicates that TRC is in the grey zone with still only limited risk for bankruptcy at the moment.
TRC's Altman-Z score of 2.42 is fine compared to the rest of the industry. TRC outperforms 67.69% of its industry peers.
TRC has a Debt/Equity ratio of 0.16. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of TRC (0.16) is better than 72.31% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Altman-Z 2.42
ROIC/WACCN/A
WACC8.54%
TRC Yearly LT Debt VS Equity VS FCFTRC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

TRC has a Current Ratio of 2.68. This indicates that TRC is financially healthy and has no problem in meeting its short term obligations.
TRC's Current ratio of 2.68 is fine compared to the rest of the industry. TRC outperforms 72.31% of its industry peers.
A Quick Ratio of 2.35 indicates that TRC has no problem at all paying its short term obligations.
With a decent Quick ratio value of 2.35, TRC is doing good in the industry, outperforming 72.31% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.68
Quick Ratio 2.35
TRC Yearly Current Assets VS Current LiabilitesTRC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 200.00% over the past year.
Measured over the past years, TRC shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -24.17% on average per year.
Looking at the last year, TRC shows a small growth in Revenue. The Revenue has grown by 7.04% in the last year.
The Revenue has been decreasing by -3.29% on average over the past years.
EPS 1Y (TTM)200%
EPS 3Y-19.39%
EPS 5Y-24.17%
EPS Q2Q%-66.67%
Revenue 1Y (TTM)7.04%
Revenue growth 3Y-9.02%
Revenue growth 5Y-3.29%
Sales Q2Q%10.84%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-17.36%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.71%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
TRC Yearly Revenue VS EstimatesTRC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
TRC Yearly EPS VS EstimatesTRC Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 0 0.2 0.4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 205.44 indicates a quite expensive valuation of TRC.
TRC's Price/Earnings ratio is in line with the industry average.
TRC is valuated expensively when we compare the Price/Earnings ratio to 27.30, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 203.41, the valuation of TRC can be described as expensive.
67.69% of the companies in the same industry are more expensive than TRC, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.76, TRC is valued quite expensively.
Industry RankSector Rank
PE 205.44
Fwd PE 203.41
TRC Price Earnings VS Forward Price EarningsTRC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TRC Per share dataTRC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for TRC!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TEJON RANCH CO

NYSE:TRC (7/11/2025, 8:04:00 PM)

After market: 18.84 +0.35 (+1.89%)

18.49

+0.12 (+0.65%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)05-08 2025-05-08/amc
Earnings (Next)07-31 2025-07-31
Inst Owners61.96%
Inst Owner Change0%
Ins Owners5.58%
Ins Owner Change1.75%
Market Cap497.01M
Analysts0
Price Target26.78 (44.84%)
Short Float %2.89%
Short Ratio5.88
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-67%
Min EPS beat(2)-595.05%
Max EPS beat(2)461.06%
EPS beat(4)2
Avg EPS beat(4)-123.76%
Min EPS beat(4)-595.05%
Max EPS beat(4)461.06%
EPS beat(8)5
Avg EPS beat(8)34.8%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)10.84%
Min Revenue beat(2)7.35%
Max Revenue beat(2)14.33%
Revenue beat(4)3
Avg Revenue beat(4)0.57%
Min Revenue beat(4)-24.9%
Max Revenue beat(4)14.33%
Revenue beat(8)4
Avg Revenue beat(8)-13.26%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-10%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 205.44
Fwd PE 203.41
P/S 11.64
P/FCF N/A
P/OCF 40.77
P/B 1.05
P/tB 1.22
EV/EBITDA N/A
EPS(TTM)0.09
EY0.49%
EPS(NY)0.09
Fwd EY0.49%
FCF(TTM)-2.5
FCFYN/A
OCF(TTM)0.45
OCFY2.45%
SpS1.59
BVpS17.58
TBVpS15.15
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.35%
ROE 0.45%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 5.01%
GM 8.1%
FCFM N/A
ROA(3y)1.27%
ROA(5y)0.93%
ROE(3y)1.56%
ROE(5y)1.15%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-12.59%
PM growth 5Y-21.37%
GM growth 3Y-35.98%
GM growth 5Y-22.35%
F-Score6
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1620.56%
Cap/Sales 185.79%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.68
Quick Ratio 2.35
Altman-Z 2.42
F-Score6
WACC8.54%
ROIC/WACCN/A
Cap/Depr(3y)810.78%
Cap/Depr(5y)692.45%
Cap/Sales(3y)82.92%
Cap/Sales(5y)71.79%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)200%
EPS 3Y-19.39%
EPS 5Y-24.17%
EPS Q2Q%-66.67%
EPS Next Y-17.36%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)7.04%
Revenue growth 3Y-9.02%
Revenue growth 5Y-3.29%
Sales Q2Q%10.84%
Revenue Next Year5.71%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-14.82%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-183.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y207.88%
OCF growth 3Y71.94%
OCF growth 5Y-2.26%